Literature DB >> 21640498

Greater postimplant swelling in small-volume prostate glands: implications for dosimetry, treatment planning, and operating room technique.

Eugene Chung1, Matthew H Stenmark, Cheryl Evans, Vrinda Narayana, Patrick W McLaughlin.   

Abstract

PURPOSE: Postimplant prostatic edema has been implicated in suboptimal permanent implants, and smaller prostates have been reported to have worse dosimetric coverage. In this study we compare the degree of postimplant edema between larger and smaller prostates and examine the effects of prostate size on the dose delivered to 90% of the prostate (D90). METHODS AND MATERIALS: From September 2003 to February 2006, 105 hormone-naive patients underwent permanent prostate brachytherapy with (125)I Rapid Strand (Oncura Inc., Arlington Heights, IL). All patients underwent pelvic magnetic resonance imaging (MRI) within 3 weeks before implant, transrectal ultrasound at the time of implant, and both computed tomography and MRI 2.5 to 3 weeks after implant. Prostates were divided into 5 subgroups based on preimplant MRI volumes: less than 25 mL, 25 to 35 mL, 35 to 45 mL, 45 to 55 mL, and greater than 55 mL. Prostate swelling was assessed by use of preimplant and postimplant MRI volumes. Postimplant dosimetry was determined by MRI and compared between the subgroups.
RESULTS: All prostates showed postimplant swelling on MRI when compared with preimplant MRI, with a mean increase of 31% ± 31% (p < 0.0001). The greatest swelling was noted in small prostates (volume less than 25 mL), with a mean increase of 70% ± 36%. The degree of swelling in the group with a volume less than 25 mL was significantly larger than the degree of swelling in all other prostate subgroups (p < 0.003). Transrectal ultrasound significantly overestimates the prostate volume when compared with MRI by a mean of 15% ± 25% (p = 0.0006) and is more pronounced for smaller prostates. Although prostates with volumes less than 25 mL did not have significantly worse D90 compared with larger prostates, they had the largest percent of suboptimal implants by the standard ratio of D90 divided by the prescription dose.
CONCLUSIONS: Although small prostates have the greatest postimplant edema, planning ultrasound at the time of implant overestimates the volumes of smaller prostates to a greater degree than larger prostates, which may minimize the effects of edema on postimplant dosimetry. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640498     DOI: 10.1016/j.ijrobp.2011.03.024

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment.

Authors:  T Shaikh; N G Zaorsky; K Ruth; D Y Chen; R E Greenberg; J Li; K Crawford; E M Horwitz
Journal:  Brachytherapy       Date:  2014-11-07       Impact factor: 2.362

Review 2.  Prostate cancer in transgender women: considerations for screening, diagnosis and management.

Authors:  Fionnuala Crowley; Meredith Mihalopoulos; Simita Gaglani; Ashutosh K Tewari; Che-Kai Tsao; Miroslav Djordjevic; Natasha Kyprianou; Rajveer S Purohit; Dara J Lundon
Journal:  Br J Cancer       Date:  2022-10-19       Impact factor: 9.075

3.  Prostate volume changes during permanent seed brachytherapy: an analysis of intra-operative variations, predictive factors and clinical implication.

Authors:  Ciprian Chira; Guila Delouya; Sandra Larrivée; Jean-Francois Carrier; Daniel Taussky
Journal:  Radiat Oncol       Date:  2013-07-09       Impact factor: 3.481

4.  Change in prostate volume during extreme hypo-fractionation analysed with MRI.

Authors:  Adalsteinn Gunnlaugsson; Elisabeth Kjellén; Oskar Hagberg; Camilla Thellenberg-Karlsson; Anders Widmark; Per Nilsson
Journal:  Radiat Oncol       Date:  2014-01-13       Impact factor: 3.481

5.  Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging.

Authors:  Guila Delouya; Jean-Francois Carrier; Renée Xavier-Larouche; Yannick Hervieux; Dominic Béliveau-Nadeau; David Donath; Daniel Taussky
Journal:  Cureus       Date:  2018-03-29

6.  Variability in MRI vs. ultrasound measures of prostate volume and its impact on treatment recommendations for favorable-risk prostate cancer patients: a case series.

Authors:  Yonina R Murciano-Goroff; Luciant D Wolfsberger; Arti Parekh; Fiona M Fennessy; Kemal Tuncali; Peter F Orio; Thomas R Niedermayr; W Warren Suh; Phillip M Devlin; Clare Mary C Tempany; Emily H Neubauer Sugar; Desmond A O'Farrell; Graeme Steele; Michael O'Leary; Ivan Buzurovic; Antonio L Damato; Robert A Cormack; Andriy Y Fedorov; Paul L Nguyen
Journal:  Radiat Oncol       Date:  2014-09-09       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.